Literature DB >> 16038762

Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection.

Mustafa Saad1, Souad Youssef, David Kirschke, Mohammed Shubair, Dafer Haddadin, James Myers, Jonathan Moorman.   

Abstract

OBJECTIVES: Acute flaccid paralysis (AFP) has recently emerged as a major central nervous system complication associated with West Nile virus (WNV) infection. The spectrum of clinical presentations of AFP in WNV infection and its sequelae have not been well-studied.
METHODS: We describe three patients with AFP due to WNV infection and review the clinical presentations of 56 patients with this complication derived from published studies.
RESULTS: Patients with AFP and WNV presented with a spectrum of illness ranging from single extremity paralysis to quadriparalysis with cranial nerve involvement. Patients commonly developed respiratory failure (54%) and bladder dysfunction (22%). While fever was nearly universal (92%), signs of meningismus were less common (17%). Cerebrospinal fluid (CSF) analysis generally revealed a modest pleocytosis, and imaging studies were not diagnositic. Persistent neurologic impairment occurred in all survivors; overall mortality rate was high (22%) and was associated with both the extent of paralysis and advanced age.
CONCLUSION: AFP in the setting of WNV is associated with significant mortality and long-term morbidity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16038762     DOI: 10.1016/j.jinf.2004.10.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  17 in total

Review 1.  Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang
Journal:  Antiviral Res       Date:  2013-09-19       Impact factor: 5.970

2.  Myelopathy in West Nile virus encephalitis: Report of a case and review of literature.

Authors:  Jayantee Kalita; Amar Vibhute; Mritunjai Kumar; Usha K Misra
Journal:  J Spinal Cord Med       Date:  2018-08-20       Impact factor: 1.985

3.  Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a new human enterovirus A71 genogroup.

Authors:  Maël Bessaud; Sylvie Pillet; Wafa Ibrahim; Marie-Line Joffret; Bruno Pozzetto; Francis Delpeyroux; Ionela Gouandjika-Vasilache
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

4.  Delayed-onset and recurrent limb weakness associated with West Nile virus infection.

Authors:  James J Sejvar; Larry E Davis; Erica Szabados; Alan C Jackson
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

5.  Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis.

Authors:  Joseph G Victoria; Amit Kapoor; Linlin Li; Olga Blinkova; Beth Slikas; Chunlin Wang; Asif Naeem; Sohail Zaidi; Eric Delwart
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 6.  Aseptic meningitis and viral myelitis.

Authors:  David N Irani
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

7.  Autonomic nervous dysfunction in hamsters infected with West Nile virus.

Authors:  Hong Wang; Venkatraman Siddharthan; Jeffery O Hall; John D Morrey
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

8.  Prognosis of West Nile virus associated acute flaccid paralysis: a case series.

Authors:  Jennie Johnstone; Steven E Hanna; Lindsay E Nicolle; Michael A Drebot; Binod Neupane; James B Mahony; Mark B Loeb
Journal:  J Med Case Rep       Date:  2011-08-19

9.  Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang; Jeffery O Hall
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 10.  Viral myelitis: an update.

Authors:  Octavia Kincaid; Howard L Lipton
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 6.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.